The atypical chemokine receptor-2 does not alter corneal graft survival but regulates early stage of corneal graft-induced lymphangiogenesis

PURPOSE: To re-evaluate the role of the atypical chemokine receptor-2 (ACKR2) in corneal graft rejection and investigate the effect of ACKR2 on inflammation-associated lymphangiogenesis using murine orthotopic corneal transplantation. METHODS: Corneal grafts were performed and evaluated in the setti...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Tian, Forrester, J. V., Graham, Gerard J., Kuffova, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153595/
https://www.ncbi.nlm.nih.gov/pubmed/30054731
http://dx.doi.org/10.1007/s00417-018-4070-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153595/
https://www.ncbi.nlm.nih.gov/pubmed/30054731
http://dx.doi.org/10.1007/s00417-018-4070-1

Ejemplares similares